@article {7461,
	title = {Carfilozomib versus bortezomib for relapsed or refractory myeloma {\textendash} Authors{\textquoteright} reply},
	journal = {The Lancet Oncology},
	volume = {17},
	year = {2016},
	note = {Export Date: 21 February 2017},
	month = {2016},
	pages = {e126},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84977540032\&doi=10.1016\%2fS1470-2045\%2816\%2900145-5\&partnerID=40\&md5=40c687754e19de4d23dabfa69079747a},
	author = {Dimopoulos, M.A. and Moreau, P. and Palumbo, A. and Chng, W.-J. and Feng, S.}
}
